Pricing Disclosure Policy 

Healthcare Pricing Disclosures

MorphoSys fully adheres to the federal, state, and local laws and regulations that govern what we do, including those that govern healthcare pricing and disclosures of costs.

Colorado Disclosure Act

This information is intended for Colorado Prescribers.

Colorado law HB 19-1131 requires the manufacturer, when engaging in prescription drug marketing to Colorado prescribers, to provide Colorado prescribers with the wholesale acquisition cost (WAC) of the manufacturer prescription drug. Also, the manufacturer must provide the names of at least three generic prescription drugs, if available, from the same therapeutic class (i.e., similar drugs that have the same or similar mechanism of action used to treat a specific condition).

MONJUVI (tafasitamab cxix) Disclosure Form

Disclaimer: This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.